WhatsApp : +91-9156233611, +91-9371136499

Best HIPEC Cancer Surgeons and Hospitals in India for Uzbek Patients: How to Choose

Learn how Uzbek patients can choose experienced HIPEC cancer surgeons and reliable hospitals in India by evaluating cytoreduction expertise, case volume, ICU support, accreditation and multidisciplinary cancer care.

Author:- Dr. Dheeraj Bojwani

HIPEC combines cytoreductive surgery with heated intraperitoneal chemotherapy, and the completeness of the surgical cytoreduction is the single strongest predictor of outcome — making the surgeon's specific technique just as important as the chemotherapy itself. Choosing where to have HIPEC in India is really two decisions at once: which surgeon, and which hospital. Across more than two decades of guiding patients from Uzbekistan to treatment in India, the questions I hear most are: How do I know a surgeon is genuinely skilled at this specific procedure? What actually makes a hospital reliable? Which matters more? And what should I ask before I commit? This guide answers each plainly, giving equal weight to both halves of the decision. India has become one of the world's leading destinations for cytoreductive surgery with HIPEC, and for good reason. The country treats a substantial volume of peritoneal surface malignancy cases every year, giving its top surgical oncology teams a depth of experience in achieving complete cytoreduction that is hard to match. Modern perfusion systems, integrated pathology support, and internationally trained surgical oncologists are now standard at India's leading centres — available at a fraction of the cost of equivalent treatment in the UK, Germany, Australia or the USA.

Healing Journeys of Uzbek Patients

Uzbek Patients Share Their Experience

Information Takeaways

  • HIPEC combines cytoreductive surgery with heated intraperitoneal chemotherapy, but the guide emphasises that the completeness of tumour removal is a particularly important determinant of outcome. Uzbek patients therefore need to assess the surgeon's cytoreductive expertise as carefully as the hospital's HIPEC infrastructure.
  • India manages a substantial volume of peritoneal surface malignancy cases, giving experienced surgical oncology teams exposure to complex cytoreductive surgery and HIPEC. The guide also highlights modern perfusion systems, integrated pathology support and international-patient coordination for Uzbek patients.
  • The eight-point surgeon checklist focuses on MCh Surgical Oncology, dedicated fellowship training in peritoneal surface oncology and HIPEC, National Medical Commission registration, professional and international society affiliation, high annual HIPEC volume, documented CC-0/CC-1 rates and an honest assessment of whether complete cytoreduction is realistically achievable.
  • The hospital checklist highlights NABH or JCI accreditation, a dedicated peritoneal surface malignancy programme, ICU experience with post-HIPEC patients, integrated pathology and oncology support, blood-bank and transfusion capacity, international-patient services and multidisciplinary tumour-board review.
  • The guide stresses that surgeon skill and hospital infrastructure should be assessed together. A highly experienced surgeon still requires an ICU familiar with the risks of post-HIPEC care, while excellent critical-care infrastructure cannot compensate for inadequate experience achieving complete cytoreduction.
  • Before confirming surgery, Uzbek patients should ask about the surgeon's HIPEC experience for their specific cancer type, personal completeness-of-cytoreduction rate, current hospital accreditation, post-HIPEC ICU experience and the financial implications if complications occur.
  • The final decision should be based on matching the patient's disease extent with a surgeon and hospital that have verifiable HIPEC experience and documented cytoreduction outcomes. The guide also recommends obtaining the full treatment plan in writing before travel, including the surgeon, hospital, planned approach and cost breakdown.

Quick Facts

Treatment
Cytoreductive surgery with HIPEC
Primary Patients
Uzbek patients seeking HIPEC cancer treatment in India
Main Speciality
Surgical oncology and peritoneal surface oncology
Key Specialist
Surgical oncologist with dedicated HIPEC experience
Core Treatment
Cytoreductive surgery combined with heated intraperitoneal chemotherapy
Specialist Qualification
MCh Surgical Oncology
Additional Training
Fellowship in peritoneal surface oncology and HIPEC
Registration
National Medical Commission registration should be verified
Case Volume
Ask specifically about annual HIPEC procedures
Key Outcome Measure
Documented completeness-of-cytoreduction, particularly CC-0/CC-1 rates
Candidacy
Depends heavily on disease extent and whether complete cytoreduction is realistically achievable
Hospital Accreditation
NABH should be checked; JCI may provide an additional accreditation benchmark
Hospital Programme
Dedicated peritoneal surface malignancy programme
Critical Care
ICU with documented post-HIPEC experience
Pathology Support
Integrated pathology and oncology services
Blood Support
Adequate blood-bank and transfusion capacity
Multidisciplinary Care
Tumour-board review should assess HIPEC suitability
International Support
Russian- and Uzbek-speaking coordinators may be available
Documentation
Obtain the complete treatment plan and cost breakdown in writing
Cities Mentioned
Delhi, Mumbai, Chennai, Bengaluru and Hyderabad
Follow-Up
Post-operative and oncology follow-up should be planned before travel
Author
Dr. Dheeraj Bojwani
Experience
24+ Years

Knowledgeable Information Snippet

For Uzbek patients considering HIPEC cancer surgery in India, the most important selection factors are specialised peritoneal surface oncology training, high HIPEC case volume, documented CC-0/CC-1 outcomes, appropriate hospital accreditation, post-HIPEC critical-care expertise, integrated pathology and oncology support, transfusion capacity and multidisciplinary review. The guide particularly advises patients to ask whether their disease extent makes complete cytoreduction realistically achievable rather than choosing HIPEC simply because the technology is available.

Why Are Uzbek Patients Choosing India for HIPEC?

For Uzbek patients specifically, India offers dedicated Russian and Uzbek-speaking coordinators, streamlined medical visa processes, and convenient direct and connecting flights from Tashkent to Delhi, Mumbai, Chennai, Bengaluru and Hyderabad. But none of this matters if the specific surgeon and hospital you choose are not genuinely well-qualified — which is exactly why the criteria below deserve careful attention.

What Qualifications Should Your HIPEC Surgeon in India Have?

A surgeon's qualifications tell you whether they have the training and track record to achieve complete cytoreduction safely — not just general surgical oncology competence, but specific, verifiable markers of peritoneal surface malignancy expertise.

Surgeon qualifications: what to verify

Eight markers of genuine HIPEC expertise

1
MCh Surgical Oncology
The foundational super-speciality qualification required before focusing on peritoneal surface malignancy specifically.
2
Dedicated fellowship in peritoneal surface oncology and HIPEC
Additional structured training in cytoreductive surgery and HIPEC technique specifically, beyond general oncology training.
3
National Medical Commission registration
Confirms the surgeon is licensed to practise medicine in India — verifiable directly.
4
Indian Society of Peritoneal Surface Malignancies membership
Signals ongoing engagement with India's professional peritoneal oncology community and standards.
5
International society affiliation
Membership of bodies such as the Peritoneal Surface Oncology Group International (PSOGI) reflects global best practice.
6
High annual HIPEC case volume
Ask about numbers specifically for HIPEC procedures, not general oncology surgery volume.
7
Documented completeness-of-cytoreduction (CC) scores
A surgeon who tracks and can discuss their own CC-0/CC-1 rate demonstrates genuine attention to the outcome measure that matters most.
8
Honest discussion of whether HIPEC is genuinely appropriate
A genuinely expert surgeon discusses candidly whether your specific disease extent makes complete cytoreduction realistic.

Ask your prospective surgeon directly about each of these — a confident, specific answer is itself a good sign.

What Makes a Hospital in India Safe and Reliable for HIPEC?

Even an outstanding surgical oncologist needs the right environment to deliver a good outcome. HIPEC is a long, complex procedure that depends heavily on hospital-level critical care and support systems.

Hospital standards: what to verify

Eight markers of a genuinely reliable HIPEC centre

1
NABH accreditation
India's national quality standard, covering patient safety, infection control and surgical protocols.
2
JCI accreditation (where available)
The internationally recognised gold standard, verified through independent, unannounced audits.
3
Dedicated peritoneal surface malignancy programme
A hospital-level track record of high volume specifically in cytoreductive surgery and HIPEC, not occasional cases.
4
Intensive care unit experienced with post-HIPEC patients
Post-operative care after this long, complex procedure calls for ICU staff genuinely familiar with its specific risks.
5
Integrated pathology and oncology support
Rapid, coordinated pathology results support decisions made during and after the extensive surgery.
6
Blood bank and transfusion capacity
HIPEC surgery carries meaningful bleeding risk, making prompt blood availability an important safety factor.
7
International patient department
Russian and Uzbek-speaking coordinators, visa assistance, and clear communication throughout.
8
Multidisciplinary tumor board confirming HIPEC is appropriate
Surgical, medical oncology and radiology review of whether complete cytoreduction is realistically achievable for your case.

NABH and JCI accreditation status can be verified independently — a reputable hospital will not hesitate to share its current certificate.

The single strongest predictor of a good HIPEC outcome is how completely the visible tumour is removed. Ask your surgeon directly about their own CC-0/CC-1 rate, not just their overall case count.

Surgeon Skill or Hospital Infrastructure — Which Matters More?

This is not really an either-or question, and treating it as one leads patients astray. An outstanding surgical oncologist operating in a hospital without an ICU experienced in post-HIPEC care is still exposed to real risk that skill alone cannot eliminate. Equally, an excellent ICU does not compensate for a surgeon without genuine experience achieving complete cytoreduction.

The most reliable approach is to evaluate both together, since the strongest outcomes come from centres where an experienced, fellowship-trained surgeon operates within a well-accredited hospital with genuinely robust critical care support. Ask about the surgeon's specific CC-0/CC-1 rate, and whether the hospital's ICU has documented experience managing post-HIPEC patients. A surgeon who has performed consistent volume within the same well-resourced hospital system for years often represents the strongest combination of the two factors this guide has described.

Questions to Ask Before You Confirm Your HIPEC Surgery in India

Once you have a shortlist of surgeons and hospitals, these direct questions will tell you more than any marketing material. In more than 24 years of guiding patients through this exact decision, those who ask these questions plainly get the clearest, most useful answers.

Six questions to ask before you commit

Direct questions that reveal genuine quality

1
Can I verify your National Medical Commission registration number?
A confident, immediate answer confirms the surgeon is properly licensed.
2
How many HIPEC procedures have you personally performed for my cancer type?
This should be a specific number for your exact diagnosis, not general oncology surgery volume.
3
What is your own completeness-of-cytoreduction (CC) rate?
A genuinely skilled surgeon can answer this directly with a specific figure.
4
Is this hospital currently NABH or JCI accredited?
Ask to see the current certificate — accreditation can lapse and should be active.
5
Does your ICU have documented experience managing post-HIPEC patients specifically?
A confident, specific answer reflects genuine attention to this procedure's particular post-operative risks.
6
What happens, and what does it cost, if a complication arises?
A reputable centre will discuss this honestly rather than avoiding the question.

A reputable surgeon and hospital will welcome these questions. Hesitation or vague answers are themselves useful information.

Two further points: ask for direct contact with previous international patients if the hospital offers this, since a genuine testimonial carries real weight — and get your full treatment plan in writing before you travel, including the surgeon's name, hospital, planned approach, and cost breakdown.

Making Your Final Decision

By this point you should have a shortlist where both the surgeon and the hospital independently meet the criteria in this guide — not a hospital chosen simply because it offers HIPEC, without confirming genuine cytoreduction outcomes and ICU experience. Cities such as Delhi, Mumbai, Chennai, Bengaluru and Hyderabad all have centres meeting this standard, and the right choice for you depends on matching your specific disease extent to a surgeon and hospital with genuine, verifiable experience. Take the time to ask the direct questions above before committing — it is the single most useful thing you can do to protect your outcome.

A note from Dr Dheeraj Bojwani

With 24+ years of experience guiding international patients through exactly this decision, my advice is simple: ask directly about the surgeon's completeness-of-cytoreduction rate, confirm the hospital's ICU has genuine post-HIPEC experience, and never choose a centre based on the availability of the procedure alone. This article is general information and not a substitute for direct verification with your chosen surgeon and hospital.

Straight Answer Question by Uzbek Patients about Best HIPEC Cancer Surgeons and Hospitals in India

What qualifications should a HIPEC surgeon in India have?

Look for MCh Surgical Oncology, a dedicated fellowship in peritoneal surface oncology and HIPEC, National Medical Commission registration, and a documented completeness-of-cytoreduction rate.

What accreditation should a hospital have for HIPEC?

Look for NABH accreditation at minimum, and ideally JCI accreditation as well. Both are verified through independent audits and indicate the hospital meets defined standards for safety and surgical protocols.

Is HIPEC suitable for every stage of peritoneal cancer spread?

No. Suitability depends heavily on how completely the visible tumour can realistically be removed. A genuinely expert surgeon will assess your imaging and disease extent honestly before recommending HIPEC.

How can I verify credentials before I travel?

Ask the hospital's international patient department directly for the surgeon's registration number, peritoneal oncology fellowship certificates, HIPEC case volume and CC rate, and the hospital's current accreditation certificate.

References & sources

  • 🌐 National Accreditation Board for Hospitals & Healthcare Providers (NABH) — accreditation standards and hospital directory. · nabh.co
  • 🌐 Joint Commission International (JCI) — accreditation standards and directory of accredited organisations. · jointcommissioninternational.org
  • 🌐 National Medical Commission of India — doctor registration verification. · nmc.org.in
  • 🌐 Indian Society of Peritoneal Surface Malignancies — professional resources. · ispsm.org
  • 🌐 Bureau of Immigration, Government of India — e-Medical Visa. · indianvisaonline.gov.in
  • 🌐 Criteria compiled from published hospital accreditation standards and international medical travel guidance, 2025–2026.

Frequently Asked Questions by Uzbek Patients about Best HIPEC Cancer Surgeons and Hospitals in India

Is HIPEC cancer surgery available in India for Uzbek patients?

Yes. The guide specifically addresses cytoreductive surgery with HIPEC for Uzbek patients and highlights Indian centres with experience in peritoneal surface malignancy treatment.

What qualifications should a HIPEC surgeon in India have for Uzbek patients?

The guide recommends MCh Surgical Oncology, dedicated fellowship training in peritoneal surface oncology and HIPEC, verified National Medical Commission registration and substantial HIPEC-specific experience.

How should Uzbek patients evaluate a HIPEC surgeon's experience?

Patients should ask about the surgeon's annual HIPEC case volume specifically for their cancer type rather than relying on general oncology surgery numbers. The guide also recommends asking for the surgeon's own CC-0/CC-1 rate.

What is a CC-0 or CC-1 score in HIPEC surgery?

These scores describe the completeness of cytoreduction, meaning how much visible tumour remains after surgery. The guide identifies the surgeon's documented CC-0/CC-1 rate as an important outcome measure.

Is HIPEC suitable for every Uzbek patient with peritoneal cancer?

No. Suitability depends heavily on the extent of disease and whether complete cytoreduction can realistically be achieved. A specialist should assess the patient's imaging and disease extent before recommending HIPEC.

What hospital accreditation should Uzbek patients look for HIPEC?

The guide recommends NABH accreditation at minimum and JCI accreditation where available. Patients should request the current accreditation certificate before confirming treatment.

Why is ICU experience important after HIPEC surgery?

HIPEC is a long and complex procedure, and post-operative management can involve significant risks. The guide therefore recommends choosing a hospital whose ICU team has documented experience caring for post-HIPEC patients.

Does a HIPEC hospital need a multidisciplinary tumour board?

The guide recommends multidisciplinary review involving surgical, medical oncology and radiology specialists to determine whether complete cytoreduction is realistically achievable for the patient's case.

What should Uzbek patients ask about if a HIPEC complication occurs?

Patients should ask what happens if a complication arises and what additional treatment may cost. A reputable surgeon and hospital should provide a clear answer rather than avoiding the issue.

What should Uzbek patients obtain before travelling to India for HIPEC?

They should verify the surgeon's registration, HIPEC training, case volume and CC-0/CC-1 rate, confirm the hospital's current accreditation and obtain a written treatment plan identifying the surgeon, hospital, planned approach and cost breakdown.

Page Summary

HIPEC is a complex cancer procedure in which cytoreductive surgery and heated intraperitoneal chemotherapy are combined. For Uzbek patients, selecting the right surgeon requires attention to specialised peritoneal oncology training, HIPEC volume and the surgeon's ability to achieve complete cytoreduction, rather than relying only on general surgical oncology credentials. Hospital capability is equally important because HIPEC can require substantial critical-care, pathology and transfusion support. Uzbek patients should compare accreditation, ICU experience, multidisciplinary assessment and documented outcomes, then obtain a written treatment plan before travelling to India.

Citation Block

Field Details
Article / Topic HIPEC cancer surgery in India
Primary Patient Country Uzbekistan
Treatment Type Cytoreductive surgery with HIPEC
Cancer Setting Peritoneal surface malignancy
Core Treatment Principle Remove visible tumour as completely as realistically possible, followed by heated intraperitoneal chemotherapy
Surgeon Qualification MCh Surgical Oncology
Additional Training Fellowship in peritoneal surface oncology and HIPEC
Medical Registration National Medical Commission registration
Professional Membership Indian Society of Peritoneal Surface Malignancies
International Affiliation Peritoneal Surface Oncology Group International or similar organisation
HIPEC Experience High annual HIPEC case volume
Outcome Measure Documented CC-0/CC-1 completeness-of-cytoreduction rate
Candidacy Assessment Disease extent and realistic possibility of complete cytoreduction
Hospital Accreditation NABH
Additional Accreditation JCI where available
Hospital Programme Dedicated peritoneal surface malignancy programme
Critical Care ICU experienced with post-HIPEC patients
Pathology Support Integrated pathology and oncology services
Transfusion Support Blood bank and transfusion capacity
Multidisciplinary Review Surgical, medical oncology and radiology assessment
International Patient Support Russian- and Uzbek-speaking coordinators and visa assistance
Treatment Documentation Written plan covering surgeon, hospital, approach and cost
Potential Treatment Cities Delhi, Mumbai, Chennai, Bengaluru and Hyderabad

About The Author

Dr. Dheeraj Bojwani

Medical Content Writer & Reviewer
Medical Travel Advisor & International Patient Counsellor
24+ Years of Experience   •   5,000+ International Patients Assisted

Dr. Dheeraj Bojwani is a Medical Travel Advisor with over 24 years of experience assisting international patients seeking treatment in India. He has helped more than 5,000 patients from Africa, the Middle East, Europe, the USA, Asia, and other regions access treatment in leading hospitals across India.

Author & Contact Details:

Our Mission Statement

Our mission is to place patients at the centre of every healthcare decision by providing trustworthy, evidence-based, and unbiased medical information. We believe that informed patients make better decisions. Backed by personalised guidance from our experienced advisory team, we help patients understand their treatment options, compare them objectively, and confidently choose the path that best suits their medical needs and personal circumstances.

Patient Testimonials from Uzbekistan

Mr. Otabek Saidov

Mr. Otabek Saidov

Adrenal Gland Surgery in India
Uzbekistan

After months of unexplained symptoms traced to an adrenal gland growth, Mr. Otabek Saidov, 51, travelled from Uzbekistan to India for surgery with Indian Health Guru. Closely monitored through recovery, his symptoms gradually resolved. “I'm glad I chose to go where the expertise was,” he shared.

Read More
Mr. Anvar Rakhimov

Mr. Anvar Rakhimov

Bladder Cancer Surgery in India
Uzbekistan

Approaching his bladder cancer diagnosis practically, Mr. Anvar Rakhimov, 55, travelled from Uzbekistan to India for a Bladder Cancer Surgery with Indian Health Guru. With clear communication and consistent monitoring, he began recovery on solid ground. “I'm glad I chose a team that matched my approach,” he shared.

Read More
Ms. Gulnora Karimova

Ms. Gulnora Karimova

Endometriosis Surgery in India
Uzbekistan

After decades of managing endometriosis, Ms. Gulnora Karimova, 55, travelled from Uzbekistan to India for surgery with Indian Health Guru. Closely supported through recovery, she found lasting relief. “The relief I've felt since surgery is something I hadn't experienced in decades,” she shared.

Read More
Mr. Bekzod Nematov

Mr. Bekzod Nematov

CAR T Cell Therapy for Cancer in India
Uzbekistan

After earlier treatments fell short, Mr. Bekzod Nematov, 50, travelled from Uzbekistan to India for CAR T Cell Therapy with Indian Health Guru. His family found honesty and dignity at every step. “We know he received the best possible care,” his wife shared.

Read More
Mr. Sardor Karimov

Mr. Sardor Karimov

Lumbar Decompression Surgery in India
Uzbekistan

With back and leg pain controlling his daily life, Mr. Sardor Karimov, 60, travelled from Uzbekistan to India for a Lumbar Decompression Surgery with Indian Health Guru. Closely guided through recovery, the pain finally lifted. “I can move the way I used to,” he shared.

Read More
Ms. Feruza Rashidova

Ms. Feruza Rashidova

Sleeve Gastrectomy Surgery in India
Uzbekistan

After years of unsuccessful attempts, Ms. Feruza Rashidova, 45, sought a lasting solution and found Indian Health Guru. Her Sleeve Gastrectomy Surgery in India came with structured support and practical dietary guidance. “I finally feel like I have a sustainable foundation to build from,” she shared.

Read More
Mr. Bahodir Yusupov

Mr. Bahodir Yusupov

Pituitary Tumor Surgery in India
Uzbekistan

Months of unexplained symptoms led Mr. Bahodir Yusupov, 58, from Uzbekistan to a pituitary tumor diagnosis and eventually to Indian Health Guru. His Pituitary Tumor Surgery in India was followed by thorough monitoring. “Both my vision and my energy are improving,” he shared.

Read More
Mr. Jahongir Nazarov

Mr. Jahongir Nazarov

ACL Reconstruction Surgery in India
Uzbekistan

After an ACL tear ended his activity, Mr. Jahongir Nazarov, 38, travelled from Uzbekistan to India for reconstruction with Indian Health Guru. Structured physiotherapy brought his knee stability back. “I'm finally getting back to where I was before,” he shared.

Read More
Ms. Malika Abdullayeva

Ms. Malika Abdullayeva

Robotic GI Surgery in India
Uzbekistan

When her GI condition required surgery, Ms. Malika Abdullayeva, 52, chose a robotic approach and Indian Health Guru. Her Robotic GI Surgery in India came with clear guidance and structured aftercare. “The discomfort I'd been managing is gone,” she shared.

Read More
Mr. Ulugbek Rashidov

Mr. Ulugbek Rashidov

Revision Hip Joint Replacement Surgery in India: Mr. Ulugbek Rashidov from Uzbekistan
Uzbekistan

When his original hip implant began to fail, Mr. Ulugbek Rashidov, 48, turned to Indian Health Guru for a Revision Hip Joint Replacement Surgery in India. Supported through a more complex recovery, stability returned. “I finally feel stable again in a way I hadn't for years,” he shared.

Read More
Mr. Farrukh Abdullayev

Mr. Farrukh Abdullayev

CABG and Valve Replacement Surgery in India: Mr. Farrukh Abdullayev from Uzbekistan
Uzbekistan

Needing both bypass and valve surgery together, Mr. Farrukh Abdullayev, 62, trusted Indian Health Guru for his CABG and Valve Replacement Surgery in India. Recovery was steady and his family supported throughout. “I'm grateful for the seriousness with which my care was approached,” he shared.

Read More
Ms. Dilnoza Tashpulatova

Ms. Dilnoza Tashpulatova

Breast Cancer Surgery in India
Uzbekistan

When a breast cancer diagnosis changed her world, Ms. Dilnoza Tashpulatova, 48, sought care abroad and found Indian Health Guru. Her Breast Cancer Surgery in India was handled with precision and consistent support. “I'm grateful for every person who was part of my care,” she shared.

Read More
Mr. Sherzod Ergashev

Mr. Sherzod Ergashev

Gynecomastia Surgery in India
Uzbekistan

After years of living with gynecomastia privately, Mr. Sherzod Ergashev, 36, travelled from Uzbekistan to India for a Gynecomastia Surgery with Indian Health Guru. Handled with professionalism and care, he returned home with genuine confidence. “I finally feel comfortable in my own skin,” he shared.

Read More
Mr. Rustam Yuldashev

Mr. Rustam Yuldashev

Corneal Transplant Surgery in India
Uzbekistan

With his vision progressively failing, Mr. Rustam Yuldashev, 40, travelled from Uzbekistan to India for a Corneal Transplant Surgery with Indian Health Guru. Closely supported through recovery, his sight has improved significantly. “My vision has improved more than I thought possible,” he shared.

Read More
Ms. Nilufar Yusupova

Ms. Nilufar Yusupova

Heart Transplant Surgery in India
Uzbekistan

Facing end-stage heart failure, Ms. Nilufar Yusupova, 48, travelled from Uzbekistan to India for a Heart Transplant Surgery with Indian Health Guru. Her family found honest, compassionate support throughout. “We are deeply grateful for the care and humanity shown to our family,” her husband shared.

Read More

Ready to Take the First Step?

Share your medical reports with our healthcare managers today and receive a FREE CONSULTATION, a personalized treatment plan and complete support from your arrival to your recovery.

Get Your Free Consultation

From Uzbekistan to India: Your Complete Patient Guide

Read More Uzbek Patient Support Guides

WhatsApp
Enquiry